awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36376264-F880898C-DBE7-49D5-9552-885C69F2A8DC
Q36376264-F880898C-DBE7-49D5-9552-885C69F2A8DC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36376264-F880898C-DBE7-49D5-9552-885C69F2A8DC
SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma.
P2860
Q36376264-F880898C-DBE7-49D5-9552-885C69F2A8DC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36376264-F880898C-DBE7-49D5-9552-885C69F2A8DC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a1e2ff6306cd613abf2dd5c90884654e5dda8eb6
P2860
Potent in vitro and in vivo antitumor activity of sorafenib against human intrahepatic cholangiocarcinoma cells.